Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
Kalkine: Iron Ore Faces Pressure Amid China’s Construction Dip: What it Means for ASX200 Stocks
Market Updates

Kalkine: Iron Ore Faces Pressure Amid China’s Construction Dip: What it Means for ASX200 Stocks

Highlights,China’s property sector slowdown hits iron ore outlook,Stimulus hopes pushed to early H2 2025,Impact,likely on,S&P/ASX200 mining and resource stocks,China's construction sector, particularly in property development, continues to show signs of w...

Kalkine: Amber Electric Charges Ahead with $45M Raise for Global Energy Tech Expansion Amid ASX200 Momentum
Technology Stocks

Kalkine: Amber Electric Charges Ahead with $45M Raise for Global Energy Tech Expansion Amid ASX200 Momentum

Highlights,Amber Electric secures $45M for global energy tech rollout,Focused expansion into Europe with smart battery automation,Poised for growth ahead of Australia’s home battery rebate,Australian smart energy technology company,Amber Electric (ASX:AMB...

Kalkline: ASX200 Powers Ahead: Energy and Mining Stocks Fuel Market Momentum
Market Updates

Kalkline: ASX200 Powers Ahead: Energy and Mining Stocks Fuel Market Momentum

Highlights,ASX climbs alongside US market optimism,Energy, mining, and,aluminium,stocks lead rally,IDP Education rebounds after steep drop,Australian equities surged early Wednesday, following a positive lead from Wall Street as renewed optimism over the ...

Kalkine: Mayne Pharma Faces ASX200 Uncertainty as Cosette Remains Silent on $672M Takeover
Healthcare Stocks

Kalkine: Mayne Pharma Faces ASX200 Uncertainty as Cosette Remains Silent on $672M Takeover

Highlights,Mayne Pharma awaits clarity from Cosette on proposed deal,FDA concerns addressed, says Mayne,Share price trades well below offer value,Mayne Pharma (ASX:MYX) finds itself in a critical phase as it awaits a formal response from US-based Cosette ...

Kalkine: ASX200 Rallies as Commonwealth Bank (ASX:CBA) Hits All-Time High Near $180
Financial Stocks

Kalkine: ASX200 Rallies as Commonwealth Bank (ASX:CBA) Hits All-Time High Near $180

Highlights,Commonwealth Bank (CBA) reaches record high,Outpaces financial peers on the ASX200,Positive market sentiment fuels early trading rally,Australia’s largest bank, Commonwealth Bank (ASX:CBA), soared to new heights on Wednesday morning, reflecting...

Kalkline: Terra Metals Advances Copper Exploration at Dante Project with ASX200 Growth Potential
Metal & Mining Stocks

Kalkline: Terra Metals Advances Copper Exploration at Dante Project with ASX200 Growth Potential

Highlights,Terra secures approvals for Phase 3 drilling at Dante Project,New targets include EM anomalies and outcropping reef layers,Exploration expands into HRM tenements and Dante East zone,Terra Metals (ASX:TM1),has taken a significant step forward in...

WOGI Deepens Client and Merchant Ecosystem with UNIQGIFT Acquisition and New COO
PRNews

WOGI Deepens Client and Merchant Ecosystem with UNIQGIFT Acquisition and New COO

By integrating UNIQGIFT and appointing Gregory Imbert as COO, WOGI enhances its operational strength to expand merchant partnerships and deepen client relationships. SINGAPORE, June 4, 2025 /PRNews...

  • June 04, 2025 10:07 AM AEST
  • Cision
J.S. Held Announces the First Global Consulting Company Chief Intellectual Property Officer
PRNews

J.S. Held Announces the First Global Consulting Company Chief Intellectual Property Officer

JERICHO, N.Y., June 4, 2025 /PRNewswire/ -- Global consulting firm J.S. Held proudly announces the appointment of intellectual property (IP) expert James E. Malackowski as the first Chief...

  • June 04, 2025 10:07 AM AEST
  • Cision
2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from the Phase 1 PoC Clinical Study in Advanced Non-small Cell Lung Cancer
PRNews

2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from the Phase 1 PoC Clinical Study in Advanced Non-small Cell Lung Cancer

SAN FRANCISCO and SUZHOU, China, June 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and com...

  • June 04, 2025 10:00 AM AEST
  • Cision
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
PRNews

Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer

News Summary Up to six-fold increase in performance robustness with StepWave™ XR Ion Guide versus Xevo TQ Absolute.1 Uses up to 50% less power and gas, and occupies up to 50% less bench spac...

  • June 04, 2025 10:00 AM AEST
  • Cision
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.